COMMUNIQUÉS West-GlobeNewswire

Sientra to Present at the William Blair 38th Annual Growth Stock Conference

04/06/2018 - 22:01

SANTA BARBARA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, and Patrick F. Williams, Chief [...]

PolarityTE Announces Public Offering of Common Stock

04/06/2018 - 22:01

SALT LAKE CITY, June 04, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

HEALTH FOUNDATION OF SOUTH FLORIDA ELECTS DIONNE E. WONG TO BOARD OF DIRECTORS

04/06/2018 - 21:07

MIAMI,FL-, June 04, 2018 (GLOBE NEWSWIRE) -- Health Foundation of South Florida announced the election of Dionne E. Wong to its Board of Directors. The board leads the largest philanthropy dedicated to improving health [...]

The Association of Ontario Health Centres is Now Alliance for Healthier Communities

04/06/2018 - 20:50

TORONTO, June 04, 2018 (GLOBE NEWSWIRE) -- Ontario’s voice for community-governed comprehensive primary health care has a new name, and it’s official as of today: Alliance for Healthier Communities . Members of the [...]

L'Association des centres de santé de l’Ontario devient l’Alliance pour des communautés en santé

04/06/2018 - 20:50

TORONTO, 04 juin 2018 (GLOBE NEWSWIRE) -- La voix de l’Ontario pour les soins primaires complets et régis par la communauté porte un nouveau nom, et c’est officiel à compter d’aujourd’hui : l’ Alliance pour des [...]

Rafael Pharmaceuticals to Present at 2018 BIO International Convention

04/06/2018 - 20:33

Rafael was nominated in the Pipelines of Promise category this year Newark, NJ, June 04, 2018 (GLOBE NEWSWIRE) -- Sanjeev Luther, President & CEO of Rafael Pharmaceuticals, Inc., will present the company’s clinical [...]

Sanofi: New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma

04/06/2018 - 20:16

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma Patients treated with [...]

Sanofi : Le New England Journal of Medicine publie les résultats positifs d'essais cliniques pivots du cemiplimab dans le traitement de carcinome épidermoïde cutané au stade avancé

04/06/2018 - 20:16

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Le New England Journal of Medicine publie les résultats positifs d'essais cliniques pivots du cemiplimab dans le traitement de carcinome épidermoïde [...]

Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

04/06/2018 - 20:15

Overall Response Rate (ORR) of 70% and 6-month Progression Free Survival (PFS) rate of 76% in Patients Naïve to Anti-PD-1 Treatment who Received the ≤ 2mg Dose of SD -101 Combination showed Similar Rates of Immune- [...]

RadNet, Inc. to Present at the Jefferies 2018 Healthcare Conference on June 7, 2018

04/06/2018 - 19:06

LOS ANGELES, June 04, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient [...]

Ossur Hf : Transactions in relation to share buyback program

04/06/2018 - 18:00

Announcement no. 38/2018 Reykjavik, 4 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

Sensorion’s Chair of Scientific Advisory Board, Prof. Christine Petit, Awarded 2018 Kavli Prize in Neuroscience

04/06/2018 - 17:35

Christine Petit, A. James Hudspeth, and Robert Fettiplace recognized for their pioneering work on the molecular and neural mechanisms of hearing. MONTPELLIER, France, June 04, 2018 (GLOBE NEWSWIRE) -- Sensorion ( [...]

Veloxis Partners with the American Society of Transplant Surgeons to Award First Annual ASTS-Veloxis Fellowship in Transplantation

04/06/2018 - 17:05

Investor News no. 02/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 04 June 2018 Veloxis Partners with the American Society of Transplant Surgeons to Award First Annual ASTS-Veloxis Fellowship in Transplantation [...]

Helsinn: Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center

04/06/2018 - 16:10

Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center Lugano, [...]

Shire plc : Director/PDMR Shareholding

04/06/2018 - 16:01

Director/PDMR Shareholding June 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Ernst & Young LLP (EY) Announces Nelipak CEO Mike Kelly as Entrepreneur of the Year® 2018 Award Finalist for New England Region

04/06/2018 - 16:00

BOSTON, June 04, 2018 (GLOBE NEWSWIRE) -- EY today announced that Mike Kelly, president and CEO of Nelipak ® Healthcare Packaging (“Nelipak”), a full-service global provider of custom thermoformed packaging that [...]

VAYA™ Pharma Launches Vayarin® Plus Medical Food for the Management of ADHD in Adults and Adolescents

04/06/2018 - 15:23

New Non-Drug Medical Food Clinically Shown to Improve ADHD Behaviors in Adults COLUMBIA, MD., June 04, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Industries Ltd. (LSE:FRUT) (TASE:FRUT) [...]

Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018

04/06/2018 - 15:01

Favorable Tolerability Profile and Early Signs of Efficacy Demonstrated First Disclosure of Clinical Data from Novel Dolaflexin Platform Mersana To Host Conference Call and Webcast Including Principal Investigator, [...]

TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology

04/06/2018 - 15:00

CHICAGO, June 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced updated clinical data from its ongoing Phase 2 study evaluating umbralisib (TGR-1202), the Company’s PI3K delta inhibitor, [...]